Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2024.12.102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Hanseul Cho und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, …. Hauptthemen laut MEDLINE: Antipsychotic Agents, Pregnancy Complications, Pregnancy Outcome, Abnormalities, Drug-Induced. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Despite the increasing use of antipsychotics during pregnancy, comprehensive evaluations of their individual safety profiles using global data remain limited. This study aimed to assess the safety of various antipsychotics during pregnancy by comparing them to quetiapine, which has a relatively large body of safety data. METHOD: Utilizing the World Health Organization pharmacovigilance database (1968-2023; n = 131,255,418 reports), we identified 11,406 reports of antipsychotic exposure during pregnancy. A disproportionality analysis was performed to calculate reporting odds ratios (RORs) for adverse pregnancy, fetal, or neonatal outcomes associated with haloperidol, ziprasidone, clozapine, olanzapine, risperidone, aripiprazole, and paliperidone, compared to quetiapine. RESULTS: Haloperidol had a significantly higher reporting frequency for congenital malformations compared to quetiapine (ROR 3.83; 95 % CI, 2.62-5.59). No statistically significant differences were found for other antipsychotics regarding congenital malformations or neonatal complications compared to quetiapine. All studied antipsychotics had lower reporting frequencies for gestational diabetes mellitus than quetiapine (overall ROR 0.22; 95 % CI, 0.18-0.28). Haloperidol, clozapine, olanzapine, risperidone, and aripiprazole were more frequently reported for abortion or stillbirth. Paliperidone and ziprasidone had similar or lower reporting frequencies for major adverse outcomes compared to quetiapine, though conclusions regarding ziprasidone are limited by the small number of reports and the relatively high proportion mentioning adverse pregnancy outcomes. LIMITATIONS: Incomplete data and reporting bias hinder establishing causality. CONCLUSIONS: Compared to quetiapine, several antipsychotics with less established safety data, particularly ziprasidone and paliperidone, have the potential to serve as safe alternatives for use during pregnancy. However, further research is needed to verify these findings and ensure the safety of these antipsychotics as treatment options during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Medicine, Kyung Hee University College of M…
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Regulatory Science, Kyung Hee University, S…
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.
- Assistance Publique-Hopitaux de Marseille, Research Centre on Health Services and Quality of Life, Aix Marseille University, Marseille, France.
- Health Unit Eni, Maputo, Mozambique; Health Unit, Eni, San Donato Milanese, Italy.
- Department of Anatomy and Neurobiology, Kyung Hee University College of Medicine, Seoul, South Korea. Electronic address: cuttyjjy@hanmail.net.
Zitieren
APA
Cho, H., Jo, H., Jeong, Y. D., Jang, W., Park, J., Yim, Y., Lee, K., Lee, H., Lee, S., Fond, G., Boyer, L., Pizzol, D., Jung, J., & Yon, D. K. (2025). Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.12.102
Vancouver
Cho H, Jo H, Jeong YD, Jang W, Park J, Yim Y, et al. Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.12.102
BibTeX
@article{Cho2025,
author = {Cho, Hanseul and Jo, Hyesu and Jeong, Yi Deun and Jang, Wonwoo and Park, Jaeyu and Yim, Yesol and Lee, Kyeongmin and Lee, Hayeon and Lee, Sooji and Fond, Guillaume and Boyer, Laurent and Pizzol, Damiano and Jung, Junyang and Yon, Dong Keon},
title = {Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2024.12.102}
}
EUVIMED